Woodbridge, CT, United States of America

Irit Lax

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 53(Granted Patents)


Location History:

  • Fair Lawn, NJ (US) (1998 - 2006)
  • Woodbridge, CT (US) (2011 - 2016)

Company Filing History:


Years Active: 1998-2016

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Impactful Innovations of Irit Lax in Receptor Tyrosine Kinase Research

Introduction

Irit Lax, an accomplished inventor based in Woodbridge, CT, has made significant contributions to the field of receptor tyrosine kinase research. With a remarkable portfolio of five patents, her work focuses on therapeutic applications that address critical health issues related to skeletal disorders and receptor signaling pathways.

Latest Patents

Irit's latest patents include groundbreaking inventions aimed at inhibiting receptor tyrosine kinases. One pivotal invention provides moieties that bind to Ig-like domains of human receptor tyrosine kinases, such as the Kit RTK or PDGFR RTK. This innovation effectively locks the ectodomain of the receptor tyrosine kinase in an inactive state, antagonizing its activity.

Another significant patent outlines a method for treating skeletal disorders resulting from fibroblast growth factor receptor (FGFR) malfunction. This invention encompasses materials and methods for identifying agents that target diseases arising from excessive FGF receptor signaling. These agents are invaluable in treating various craniofacial disorders linked to FGFR malfunction, including syndromes such as Crouzon, Apert, and Jackson-Weiss.

Career Highlights

Irit has had a distinguished career, with key positions at prestigious institutions such as New York University and Yale University. Her research endeavors have been pivotal in advancing our understanding of receptor tyrosine kinases and their implications in various diseases.

Collaborations

Throughout her career, Irit has collaborated with notable figures in the field, including Joseph Schlessinger and Haruhiko Kouhara. These partnerships have fostered a collaborative environment conducive to groundbreaking discoveries and innovations in receptor tyrosine kinase research.

Conclusion

Irit Lax stands out as a transformative inventor whose patents have the potential to revolutionize treatments for skeletal disorders and improve our understanding of receptor signaling pathways. Her contributions not only enhance scientific knowledge but also pave the way for future therapeutic advancements that could benefit countless individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…